Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
B-ENT ; 8(1): 49-52, 2012.
Article in English | MEDLINE | ID: mdl-22545391

ABSTRACT

INTRODUCTION AND AIM: Sinonasal malignant neoplasms are uncommon, with an annual incidence of less than 1/100,000. About 80% of these are squamous cell carcinoma. Adenocarcinoma and adenoid cystic carcinoma are next in frequency. Lymphoma of the nasal cavity, paranasal sinuses and nasopharynx are rare, constituting less than 5% of all extranodal lymphomas. CASE REPORT: A 47-year-old man was referred to our hospital because of severe headache and progressive facial pain. He also complained of right-sided visual acuity. He had a manifest exopthalmia with disturbed eye movements. Nasoscopy showed a large mass with atypical appearance. CT and MRI showed a bilateral ethmoid mass invading the frontal sinuses, the right orbit, the lamina cribrosa and the right frontal cerebral region, and growing posteriorly through the choana. The first biopsies were inconclusive, showing only necrotic cells and purulent inflammation with epithelial elements. A larger biopsy demonstrated a high-grade malignant tumour with necrosis. The differential diagnosis of undifferentiated sinonasal carcinoma, undifferentiated neuro-endocrine tumour or T-cell lymphoma was suggested. In the meantime our patient developed high fever and sudden-onset pancytopenia. Bone marrow punction showed 65% blasts, leading to the diagnosis of AML type M2. He was immediately referred for chemotherapy, but died in intensive care before his first session. The biopsy of the sinonasal mass was diagnosed surprisingly as a natural killer cell lymphoma stage IVB. CONCLUSIONS: Natural killer cell lymphoma is rare in Europe. The simultaneous appearance of a NK-cell lymphoma and acute myelogenous leukemia has, as far as we know, never been described in the English literature before.


Subject(s)
Leukemia, Myeloid, Acute/diagnosis , Lymphoma, Extranodal NK-T-Cell/diagnosis , Neoplasms, Multiple Primary/diagnosis , Nose Neoplasms/diagnosis , Exophthalmos/etiology , Fatal Outcome , Humans , Image Enhancement , Leukemia, Myeloid, Acute/complications , Lymphoma, Extranodal NK-T-Cell/complications , Lymphoma, Extranodal NK-T-Cell/pathology , Magnetic Resonance Imaging , Male , Middle Aged , Neoplasm Invasiveness , Neoplasms, Multiple Primary/pathology , Nose Neoplasms/complications , Nose Neoplasms/pathology , Pancytopenia/etiology , Tomography, X-Ray Computed
2.
B-ENT ; 8 Suppl 19: 83-101, 2012.
Article in English | MEDLINE | ID: mdl-23431613

ABSTRACT

In children, all ENT cavities are particularly prone to the development of chronic inflammation. This is due to many predisposing factors, of which the most common are unfavourable anatomy, absence of nasal blowing, day care attendance, allergy, immature immunity, gastro-oesophageal reflux and tobacco smoke exposure. The aim of this paper is to outline the most specific paediatric clinical aspects of chronic pharyngo-tonsillitis, rhinosinusitis, otitis media, adenoiditis and laryngotracheitis and the important influence that some of these pathologies exert on the others.


Subject(s)
Immunity, Innate/immunology , Inflammation , Otorhinolaryngologic Diseases , Child , Chronic Disease , Global Health , Humans , Inflammation/epidemiology , Inflammation/etiology , Inflammation/immunology , Morbidity/trends , Otorhinolaryngologic Diseases/epidemiology , Otorhinolaryngologic Diseases/etiology , Otorhinolaryngologic Diseases/immunology , Risk Factors
3.
B-ENT ; 8 Suppl 19: 135-66, 2012.
Article in English | MEDLINE | ID: mdl-23431617

ABSTRACT

Treatment for chronic inflammatory conditions in children should take into account the specific pathophysiological and clinical processes underlying these disorders. These guidelines provide a framework for both the medical and surgical treatment of chronic inflammatory diseases such as otitis media, allergic rhinitis and chronic rhinosinusitis, chronic inflammation of tonsils and adenoids, and laryngitis. In addition, the role of vaccinations and immunomodulatory therapies is discussed. Whenever possible, the evidence levels for specific treatments comply with the Oxford Levels of Evidence.


Subject(s)
Inflammation/therapy , Otorhinolaryngologic Diseases/therapy , Otorhinolaryngologic Surgical Procedures/methods , Practice Guidelines as Topic , Vaccination/methods , Child , Chronic Disease , Humans
SELECTION OF CITATIONS
SEARCH DETAIL